American Journal of Epidemiology Advance Access originally published online on October 15, 2008
American Journal of Epidemiology 2008 168(10):1213-1214; doi:10.1093/aje/kwn313
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology © The Author 2008. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.
LETTERS TO THE EDITOR |
FOUR AUTHORS REPLY
1 Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109
2 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502
3 National Heart, Lung, and Blood Institute, Bethesda, MD 20824
(e-mail: rprentic@fhcrc.org)
| The first 10% of the full text of this article appears below. |
In response to the letter by Dr. Shapiro (1), we would like to reiterate that a major motivation for our joint analysis (2) of Women's Health Initiative (WHI) clinical trial and observational study data on conjugated equine estrogens and breast cancer incidence, as well